BIOMAT Database Logo BIOMAT Database Logo

Methotrexate therapy of psoriasis: differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth-inhibitory effects of methotrexate. 1995

E W Jeffes, and J L McCullough, and M R Pittelkow, and A McCormick, and J Almanzor, and G Liu, and M Dang, and K Voss, and J Voss, and A Schlotzhauer
Department of Dermatology, University of California, Irvine.

Although methotrexate (MTX) is one of the most clinically effective therapies employed to treat psoriasis, the mechanism by which low-dose MTX acts to modulate the hyperplasia of psoriasis, leading to the restoration of clinically normal skin, is only partially understood. MTX has been considered a cytotoxic agent that mediates its effect primarily on proliferating or cycling epidermal cells. Recently, proliferating lymphoid cells have been identified in psoriatic lesions, raising the possibility that proliferating lymphoid cells could be another target cell that is killed by MTX. In this study, we examined the growth-inhibitory and cytotoxic effects of MTX on proliferating lymphoid cells [THP-1 (macrophage), and MOLT-4 (T cell)], epithelial cells (HeLa, and HaCat), and normal human keratinocytes (NHK) in vitro. The proliferating cells were exposed to MTX for 24 h, and placed in fresh media to mimic the transient MTX blood levels that result from once-weekly therapy. THP-1 and MOLT-4 were found to be 10-100 times more sensitive to the cytotoxic effects of MTX than were HeLa and HaCat, and more than 1000 times more sensitive than primary human keratinocytes. At MTX concentrations that would be expected to occur in vivo during once-weekly therapy, a large percentage (> 95%) of proliferating lymphoid targets would be killed, and only a small percentage (< 10%) of proliferating epidermal cells would be affected. This in vitro data suggests that in psoriasis proliferating lymphoid cells are more likely than epithelial cells to be a major cellular target of MTX in vivo.

UI MeSH Term Description Entries
D008221 Lymphoid Tissue Specialized tissues that are components of the lymphatic system. They provide fixed locations within the body where a variety of LYMPHOCYTES can form, mature and multiply. The lymphoid tissues are connected by a network of LYMPHATIC VESSELS. Lymphatic Tissue,Lymphatic Tissues,Lymphoid Tissues,Tissue, Lymphatic,Tissue, Lymphoid,Tissues, Lymphatic,Tissues, Lymphoid
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002999 Clone Cells A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed) Clones,Cell, Clone,Cells, Clone,Clone,Clone Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004847 Epithelial Cells Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional epithelial cells. Adenomatous Epithelial Cells,Columnar Glandular Epithelial Cells,Cuboidal Glandular Epithelial Cells,Glandular Epithelial Cells,Squamous Cells,Squamous Epithelial Cells,Transitional Epithelial Cells,Adenomatous Epithelial Cell,Cell, Adenomatous Epithelial,Cell, Epithelial,Cell, Glandular Epithelial,Cell, Squamous,Cell, Squamous Epithelial,Cell, Transitional Epithelial,Cells, Adenomatous Epithelial,Cells, Epithelial,Cells, Glandular Epithelial,Cells, Squamous,Cells, Squamous Epithelial,Cells, Transitional Epithelial,Epithelial Cell,Epithelial Cell, Adenomatous,Epithelial Cell, Glandular,Epithelial Cell, Squamous,Epithelial Cell, Transitional,Epithelial Cells, Adenomatous,Epithelial Cells, Glandular,Epithelial Cells, Squamous,Epithelial Cells, Transitional,Glandular Epithelial Cell,Squamous Cell,Squamous Epithelial Cell,Transitional Epithelial Cell

Related Publications

E W Jeffes, and J L McCullough, and M R Pittelkow, and A McCormick, and J Almanzor, and G Liu, and M Dang, and K Voss, and J Voss, and A Schlotzhauer
Differential lethal effect of cytotoxic agents on proliferating and nonproliferating lymphoid cells.
July 1973, Cancer research,
E W Jeffes, and J L McCullough, and M R Pittelkow, and A McCormick, and J Almanzor, and G Liu, and M Dang, and K Voss, and J Voss, and A Schlotzhauer
Sensitivity of proliferating human breast epithelial cells to hypotonic treatment.
December 1982, Journal of surgical oncology,
E W Jeffes, and J L McCullough, and M R Pittelkow, and A McCormick, and J Almanzor, and G Liu, and M Dang, and K Voss, and J Voss, and A Schlotzhauer
Differential radiation response amongst proliferating epithelial cells.
March 1978, Cell and tissue kinetics,
E W Jeffes, and J L McCullough, and M R Pittelkow, and A McCormick, and J Almanzor, and G Liu, and M Dang, and K Voss, and J Voss, and A Schlotzhauer
Mechanisms underlying the differential sensitivity of proliferating and resting cells to external factors.
January 1977, International review of cytology. Supplement,
E W Jeffes, and J L McCullough, and M R Pittelkow, and A McCormick, and J Almanzor, and G Liu, and M Dang, and K Voss, and J Voss, and A Schlotzhauer
Differential response to keratinocyte growth factor receptor and epidermal growth factor receptor ligands of proliferating and differentiating intestinal epithelial cells.
July 2004, Journal of cellular physiology,
E W Jeffes, and J L McCullough, and M R Pittelkow, and A McCormick, and J Almanzor, and G Liu, and M Dang, and K Voss, and J Voss, and A Schlotzhauer
Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.
April 1985, Cancer research,
E W Jeffes, and J L McCullough, and M R Pittelkow, and A McCormick, and J Almanzor, and G Liu, and M Dang, and K Voss, and J Voss, and A Schlotzhauer
Differential Glutamate Metabolism in Proliferating and Quiescent Mammary Epithelial Cells.
May 2016, Cell metabolism,
E W Jeffes, and J L McCullough, and M R Pittelkow, and A McCormick, and J Almanzor, and G Liu, and M Dang, and K Voss, and J Voss, and A Schlotzhauer
Responses of proliferating and non-proliferating Chinese hamster cells to cytotoxic agents.
March 1978, British journal of cancer,
E W Jeffes, and J L McCullough, and M R Pittelkow, and A McCormick, and J Almanzor, and G Liu, and M Dang, and K Voss, and J Voss, and A Schlotzhauer
Cytotoxic effects of lymphoid cells in vitro.
January 1969, Advances in immunology,
E W Jeffes, and J L McCullough, and M R Pittelkow, and A McCormick, and J Almanzor, and G Liu, and M Dang, and K Voss, and J Voss, and A Schlotzhauer
[Diurnal rhythm of the sensitivity of proliferating epithelial cells of the tongue and esophagus to adrenaline].
November 1983, Biulleten' eksperimental'noi biologii i meditsiny,
Copied contents to your clipboard!